A naukri.com initiative
Hrdive
2w
344
Image Credit: Hrdive
7 strategies to overcome the rising costs of specialty medications
- Specialty medications, such as biologics and gene therapies, represent a growing portion of global spending and pose financial challenges to healthcare systems.
- Skai Blue Cross Blue Shield focuses on managing medical pharmacy costs through a comprehensive approach.
- Establishing dedicated review practices and evaluating clinical effectiveness are strategies to manage high-cost therapies.
- Prioritizing lower-cost alternatives like biosimilars and leveraging scale to reduce net costs are key tactics employed by Skai.
- Synergie Medication Collective aims to lower wholesale costs and improve affordability for costly medical benefit drugs.
- Skai offers financial risk mitigation for high-cost cell and gene therapies through their Gene + Outcomes program.
- Streamlining prior authorization processes and optimizing site of care help reduce treatment delays and enhance patient experiences.
- Providing integrated support and empowering case managers with a comprehensive view aid in personalized and effective care for members.
- Skai Blue Cross Blue Shield's Medical Pharmacy Program is dedicated to optimizing savings and improving the overall healthcare experience.
- Skai's tailored solutions aim to pioneer better healthcare for national employers by addressing the challenges of specialty medication costs.
Read Full Article
20 Likes
For uninterrupted reading, download the app